MEI Pharma, Inc.
COMBINATION THERAPIES
Last updated:
Abstract:
Provided herein are methods of treating and sensitizing cancer comprising administering a glycolytic inhibitor and an oxidative phosphorylation inhibitor.
Status:
Application
Type:
Utility
Filling date:
16 Mar 2021
Issue date:
2 Sep 2021